The Analyst Verdict: Amgen In The Eyes Of 18 Experts

robot
Abstract generation in progress

Eighteen analysts have provided ratings for Amgen (NASDAQ: AMGN) over the past three months, with current sentiments indicating 3 bullish, 4 somewhat bullish, and 11 indifferent perspectives. The average 12-month price target for Amgen is $350.61, representing a 6.93% increase from the previous average. The article also provides detailed financial insights into Amgen’s market capitalization, revenue growth, net margin, ROE, ROA, and debt management.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)